FDA accepted Roche’s drug combo for ESR1-mutated advanced breast cancer, with review due by Dec. 18, 2026.

A new blood test may predict Alzheimer’s onset within 3–4 years, but isn’t yet reliable for healthy people.

India's Health Minister urges AIIMS reforms: patient care, AI integration, and faster hiring.

Indian generic drug maker Natco gains 11% after FDA approval for diabetes drug, amid regulatory updates and profit rise.

UAE launches Jaheziya, a national medical readiness system enhancing emergency response through simulation and training.

India's medical tourism boom sees Ahmedabad's Musk Clinic draw global patients with AI-powered, FDA-approved hair transplants.

A new AI tool predicts deadly transplant complications months in advance, helping doctors act sooner.

A new minimally invasive heart procedure is now available in Palm Beach County, offering faster recovery and lower risks for patients with severe blockages.

Doctyn Academy in New Delhi expanded medical training for doctors to boost clinical skills and patient care through hands-on, real-world practice.

Zentek updated on Feb. 17, 2026, about progress in its drug development pipeline and regulatory engagement with the FDA, without new approvals.